A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes-Reference-Cited by-同舟云学术

A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

Published:2020-03-12 Issue:7 Volume:22 Page:1111-1121
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Curtin Francois¹²^ORCID,Champion Bernard³,Davoren Peter⁴,Duke Sally⁵,Ekinci Elif I.⁶,Gilfillan Chris⁷,Morbey Claire⁸,Nathow Thomas⁹,O'Moore‐Sullivan Trisha¹⁰,O'Neal David¹¹,Roberts Adam¹²,Stranks Stephen¹³,Stuckey Bronwyn¹⁴,Vora Parind¹⁵,Malpass Sam¹⁶,Lloyd David¹⁶,Maëstracci‐Beard Nicole¹,Buffet Bénédicte¹,Kornmann Gabrielle¹,Bernard Corinne¹^ORCID,Porchet Hervé¹¹⁷,Simpson Richard⁷

Affiliation:

1. GeNeuro SA Geneva Switzerland

2. Division of Clinical Pharmacology and Toxicology, Rue Perret‐GentilUniversity of Geneva Geneva Switzerland

3. Department of Clinical Medicine, Faculty of Medicine and Health SciencesMacquarie University Macquarie Park New South Wales Australia

4. Gold Coast Hospital, Diabetes and Endocrinology Southport Queensland Australia

5. Department of Diabetes Endocrinology and MetabolismRoyal North Shore Hospital St Leonards New South Wales Australia

6. Department of MedicineAustin Health and The University of Melbourne Heidelberg Heights Victoria Australia

7. Eastern Clinical Research UnitEastern Health and Monash University Box Hill Victoria Australia

8. AIM Centre Merewether New South Wales Australia

9. Ipswich Research Institute Ipswich Queensland Australia

10. Mater Hospital South Brisbane Queensland Australia

11. St. Vincent's Hospital, Department of Medicine Fitzroy Victoria Australia

12. Barwon Health, Department of Endocrinology Geelong Victoria Australia

13. Southern Adelaide Diabetes & Endocrine Services, Flinders Medical Centre Bedford Park South Australia Australia

14. Keogh Institute for Medical ResearchQueen Elizabeth II Medical Centre Nedlands, Western Australia Australia

15. Division of Medicine, Lyell McEwin Hospital Elizabeth Vale South Australia Australia

16. Southern Star Research Gordon New South Wales Australia

17. Department of PharmacologyUniversity of Pretoria Pretoria South Africa

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14010

Reference22 articles.

1. Strategies for clinical trials in type 1 diabetes

2. Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice

3. T cells in type 1 diabetes: Instructors, regulators and effectors: A comprehensive review

4. Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target

5. An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon;World Journal of Diabetes;2024-02-15

2. Bioreceptors for Affinity Binding in Theranostic Development;Biosensors Nanotechnology;2023-09-13

3. Human Endogenous Retroviruses in Autism Spectrum Disorders: Recent Advances and New Perspectives at the Gene-Environment Interface;Autism Spectrum Disorders - Recent Advances and New Perspectives;2023-04-26

4. HERVs and Cancer—A Comprehensive Review of the Relationship of Human Endogenous Retroviruses and Human Cancers;Biomedicines;2023-03-17

5. Human Endogenous Retroviruses in Diseases;Subcellular Biochemistry;2023